These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 12644763

  • 1. Topical mitomycin treatment for primary acquired melanosis of the conjunctiva.
    Yuen VH, Jordan DR, Brownstein S, Dorey MW.
    Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):149-51. PubMed ID: 12644763
    [Abstract] [Full Text] [Related]

  • 2. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia.
    Frucht-Pery J, Pe'er J.
    Arch Ophthalmol; 1996 Oct; 114(10):1261-4. PubMed ID: 8859090
    [Abstract] [Full Text] [Related]

  • 3. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H, McCormick SA, Finger PT.
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [Abstract] [Full Text] [Related]

  • 4. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.
    Pe'er J, Frucht-Pery J.
    Am J Ophthalmol; 2005 Feb; 139(2):229-34. PubMed ID: 15733981
    [Abstract] [Full Text] [Related]

  • 5. Topical mitomycin C in the treatment of pigmented conjunctival lesions.
    Rodríguez-Ares T, Touriño R, De Rojas V, Becerra E, Capeans C.
    Cornea; 2003 Mar; 22(2):114-7. PubMed ID: 12605043
    [Abstract] [Full Text] [Related]

  • 6. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
    Kurli M, Finger PT.
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Resolution of primary acquired melanosis with atypia after minimal mitomycin C treatment.
    Chen JY, Chappell AJ, Klebe S, Mills RA.
    Clin Exp Ophthalmol; 2007 Dec; 35(9):865-7. PubMed ID: 18173419
    [Abstract] [Full Text] [Related]

  • 9. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
    Finger PT, Czechonska G, Liarikos S.
    Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
    [Abstract] [Full Text] [Related]

  • 10. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
    Werschnik C, Lommatzsch PK.
    Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
    [Abstract] [Full Text] [Related]

  • 11. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.
    Salomão DR, Mathers WD, Sutphin JE, Cuevas K, Folberg R.
    Ophthalmology; 1999 Sep; 106(9):1756-60; discussion 1761. PubMed ID: 10485547
    [Abstract] [Full Text] [Related]

  • 12. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
    Groh MJ, Holbach LM, Kühnel B, Conway RM, Naumann GO.
    Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
    [Abstract] [Full Text] [Related]

  • 13. Primary acquired melanosis with atypia treated with mitomycin C.
    Anandajeya WV, Corrêa ZM, Augsburger JJ.
    Int Ophthalmol; 2009 Aug; 29(4):285-8. PubMed ID: 18438612
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a short-term topical interferon α-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia.
    Garip A, Schaumberger MM, Wolf A, Herold TR, Miller CV, Klingenstein A, Schebitz-Walter K, Hintschich CR.
    Orbit; 2016 Aug; 35(1):29-34. PubMed ID: 26636727
    [Abstract] [Full Text] [Related]

  • 15. Progression of primary acquired melanosis with atypia during pregnancy.
    Irvine F, Kumarasamy M, Kemp E, Roberts F.
    Arch Ophthalmol; 2012 Aug; 130(8):1085-7. PubMed ID: 22893092
    [No Abstract] [Full Text] [Related]

  • 16. Corneal melanosis successfully treated using topical mitomycin-C and alcohol corneal epitheliectomy: a 3-year follow-up case report.
    Balcı M, Yağcı R, Güler E, Haltaş H, Duman R, Hepşen İF.
    Arq Bras Oftalmol; 2015 Aug; 78(4):255-6. PubMed ID: 26375344
    [Abstract] [Full Text] [Related]

  • 17. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment.
    Chalasani R, Giblin M, Conway RM.
    Clin Exp Ophthalmol; 2006 Aug; 34(7):708-14. PubMed ID: 16970772
    [Abstract] [Full Text] [Related]

  • 18. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
    Lichtinger A, Pe'er J, Frucht-Pery J, Solomon A.
    Ophthalmology; 2010 Mar; 117(3):431-7. PubMed ID: 20060167
    [Abstract] [Full Text] [Related]

  • 19. Mitomycin for pigmented conjunctival lesions.
    Char DH.
    Am J Ophthalmol; 2005 Feb; 139(2):331-2. PubMed ID: 15733996
    [No Abstract] [Full Text] [Related]

  • 20. [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years].
    Schmidt M, Maier M, Schmidt T, Klaehsen D, Merté RL.
    Klin Monbl Augenheilkd; 2001 Dec; 218(12):805-9. PubMed ID: 11805873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.